498 related articles for article (PubMed ID: 12531083)
1. Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis.
Bont L; Aalderen WM; Kimpen JL
Paediatr Respir Rev; 2000 Sep; 1(3):221-7. PubMed ID: 12531083
[TBL] [Abstract][Full Text] [Related]
2. Acute bronchiolitis in infancy as risk factor for wheezing and reduced pulmonary function by seven years in Akershus County, Norway.
Fjaerli HO; Farstad T; Rød G; Ufert GK; Gulbrandsen P; Nakstad B
BMC Pediatr; 2005 Aug; 5():31. PubMed ID: 16109158
[TBL] [Abstract][Full Text] [Related]
3. Diminished lung function, RSV infection, and respiratory morbidity in prematurely born infants.
Broughton S; Bhat R; Roberts A; Zuckerman M; Rafferty G; Greenough A
Arch Dis Child; 2006 Jan; 91(1):26-30. PubMed ID: 16188957
[TBL] [Abstract][Full Text] [Related]
4. Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up.
Valkonen H; Waris M; Ruohola A; Ruuskanen O; Heikkinen T
Allergy; 2009 Sep; 64(9):1359-65. PubMed ID: 19416146
[TBL] [Abstract][Full Text] [Related]
5. Long-term airway morbidity following viral LRTI in early infancy: recurrent wheezing or asthma?
Stein RT
Paediatr Respir Rev; 2009 Jun; 10 Suppl 1():29-31. PubMed ID: 19651399
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma.
Martinez FD
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S76-82. PubMed ID: 12671456
[TBL] [Abstract][Full Text] [Related]
7. Soluble CD14 as a predictor of subsequent development of recurrent wheezing in hospitalized young children with respiratory syncytial virus-induced bronchiolitis.
Soferman R; Bar-Zohar D; Jurgenson U; Fireman E
Ann Allergy Asthma Immunol; 2004 May; 92(5):545-8. PubMed ID: 15191023
[TBL] [Abstract][Full Text] [Related]
8. Increased airway reactivity in human RSV bronchiolitis in the guinea pig is not due to increased wall thickness.
Robinson PJ; Hegele RG; Schellenberg RR
Pediatr Pulmonol; 1996 Oct; 22(4):248-54. PubMed ID: 8905885
[TBL] [Abstract][Full Text] [Related]
9. High incidence of recurrent wheeze in children with down syndrome with and without previous respiratory syncytial virus lower respiratory tract infection.
Bloemers BL; van Furth AM; Weijerman ME; Gemke RJ; Broers CJ; Kimpen JL; Bont L
Pediatr Infect Dis J; 2010 Jan; 29(1):39-42. PubMed ID: 19907362
[TBL] [Abstract][Full Text] [Related]
10. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study.
Henderson J; Hilliard TN; Sherriff A; Stalker D; Al Shammari N; Thomas HM
Pediatr Allergy Immunol; 2005 Aug; 16(5):386-92. PubMed ID: 16101930
[TBL] [Abstract][Full Text] [Related]
11. Airflow limitation during respiratory syncytial virus lower respiratory tract infection predicts recurrent wheezing.
Bont L; Van Aalderen WM; Versteegh J; Brus F; Draaisma JT; Pekelharing-Berghuis M; Van Diemen-Steenvoorde RA; Kimpen JL
Pediatr Infect Dis J; 2001 Mar; 20(3):277-82. PubMed ID: 11303830
[TBL] [Abstract][Full Text] [Related]
12. IL-13 genetic polymorphism identifies children with late wheezing after respiratory syncytial virus infection.
Ermers MJ; Hoebee B; Hodemaekers HM; Kimman TG; Kimpen JL; Bont L
J Allergy Clin Immunol; 2007 May; 119(5):1086-91. PubMed ID: 17313976
[TBL] [Abstract][Full Text] [Related]
13. Severity of respiratory syncytial virus bronchiolitis is affected by cigarette smoke exposure and atopy.
Bradley JP; Bacharier LB; Bonfiglio J; Schechtman KB; Strunk R; Storch G; Castro M
Pediatrics; 2005 Jan; 115(1):e7-14. PubMed ID: 15629968
[TBL] [Abstract][Full Text] [Related]
14. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.
Piedimonte G
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S66-74; discussion S74-5. PubMed ID: 12671455
[TBL] [Abstract][Full Text] [Related]
15. Epidemiologic evidence of increased airway reactivity in children with a history of bronchiolitis.
Kattan M
J Pediatr; 1999 Aug; 135(2 Pt 2):8-13. PubMed ID: 10431133
[TBL] [Abstract][Full Text] [Related]
16. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing.
Simoes EA; Groothuis JR; Carbonell-Estrany X; Rieger CH; Mitchell I; Fredrick LM; Kimpen JL;
J Pediatr; 2007 Jul; 151(1):34-42, 42.e1. PubMed ID: 17586188
[TBL] [Abstract][Full Text] [Related]
17. Impact of wheezing after respiratory syncytial virus infection on health-related quality of life.
Bont L; Steijn M; van Aalderen WM; Kimpen JL
Pediatr Infect Dis J; 2004 May; 23(5):414-7. PubMed ID: 15131463
[TBL] [Abstract][Full Text] [Related]
18. Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases.
Welliver TP; Reed JL; Welliver RC
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S92-6. PubMed ID: 18820587
[TBL] [Abstract][Full Text] [Related]
19. Ethical considerations and rationale of the MAKI trial: a multicenter double-blind randomized placebo-controlled trial into the preventive effect of palivizumab on recurrent wheezing associated with respiratory syncytial virus infection in children with a gestational age of 33-35 weeks.
Blanken M; Rovers M; Sanders E; Bont L
Contemp Clin Trials; 2012 Nov; 33(6):1287-92. PubMed ID: 22820319
[TBL] [Abstract][Full Text] [Related]
20. Links between respiratory syncytial virus bronchiolitis and childhood asthma: clinical and research approaches.
Openshaw PJ; Dean GS; Culley FJ
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S58-64; discussion S64-5. PubMed ID: 12671454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
